Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02770249 2012-02-06
- 1 -
Stabilization of enzymes with stable coenzymes
Description
The present invention concerns a method for stabilizing enzymes by storing the
enzyme in the presence of a stabilized coenzyme. In addition the present
invention
concerns an enzyme stabilized with a stabilized coenzyme as well as the use
thereof
in test elements for detecting analytes.
Diagnostic test elements are important components of clinically relevant
analytical
methods. In this connection the focus is on the measurement of analytes, e.g.
metabolites or substrates, which for example can be determined directly or
indirectly with the aid of an enzyme that is specific for the analyte. In this
case the
analytes are converted with the aid of an enzyme-coenzyme complex and
subsequently quantified. This entails the analyte to be determined being
brought into
contact with a suitable enzyme, a coenzyme and optionally a mediator, whereby
the
coenzyme is physicochemically changed e.g. oxidized or reduced by the
enzymatic
reaction. If a mediator is additionally used, it usually transfers electrons
from the
reduced coenzyme released during the conversion of the analyte onto an optical
indicator or the conductive components of an electrode so that the process can
be
for example detected photometrically or electrochemically. A calibration
provides a
direct relationship between the measured value and the concentration of the
analyte
to be determined.
An important criterion when providing diagnostic test elements is their long-
term
stability. Test elements known from the prior art which are for example used
in the
determination of blood glucose are generally very sensitive to moisture and
heat,
where usually the function of in particular the coenzyme and mediator is
impaired.
Another problem of commercially available test elements is their sensitivity
to
CA 02770249 2012-02-06
- 2 -
ambient light where light absorption by the enzyme system can result in damage
to
the enzyme, coenzyme or/and mediator. In certain forms of application e.g. in
the
case of tests which are carried out by the end user himself, erroneous results
can
therefore occur due to an incorrect, unnoticed faulty storage of the
measurement
system which can be hardly detected by the user and may result in incorrect
treatment of the respective disease.
A known measure that can be used to increase the stability of diagnostic test
elements is the use of stable enzymes e.g. the use of enzymes from
thermophilic
organisms. Furthermore, it is possible to stabilize enzymes by chemical
modification e.g. cross-linking, or by mutagenesis. In addition enzyme
stabilizers
such as e.g. trehalose, polyvinyl pyrrolidone and serum albumin can also be
added
or the enzymes can be enclosed in polymer networks e.g. by
photopolymerization.
Attempts have also been made to improve the stability of diagnostic test
elements
by using stable mediators. Thus, the specificity of tests is increased and
interferences during the reaction are eliminated by using mediators with a
redox
potential that is as low as possible. However, the redox potential of the
enzyme /
coenzyme complexes form a lower limit for the redox potential of mediators. If
the
redox potential is lower than this limit, the reaction with the mediators is
slowed
down or even stopped.
Alternatively it is also possible to use diagnostic test elements without
mediators in
which for example coenzymes such as the coenzyme NADH are detected directly. A
disadvantage of such measurement systems is, however, that native coenzymes
such
as NAD and NADP are unstable.
NAD and NADP are base-labile molecules whose degradation pathways are
described in the literature (N.J. Oppenheimer, in "The Pyridine Nucleotide
Coenzyme", Academic Press New York, London 1982, editor J. Everese, B.
CA 02770249 2012-02-06
- 3 -
Anderson, K. You, chapter 3, pages 56-65). ADP-ribose is mainly formed when
NAD or NADP are degraded by cleavage of the glycosyl linkages between the
ribose and the pyridine unit. In contrast the reduced forms NADH and NADPH are
acid-labile: e.g. epimerization is a known degradation pathway. In both cases
the
instability of NAD/NADP and NADH/NADPH is due to the lability of the glycosyl
linkage between the ribose unit and the pyridine unit. However, under
conditions
that are not drastic such as e.g. an aqueous solution, the coenzymes NAD and
NADP are already hydrolyzed solely due to the ambient moisture. This
instability
may lead to inaccuracies in the measurement of analytes.
A number of NAD/NADP derivatives is described for example by B.M. Anderson
in "The Pyridine Nucleotide Coenzymes", Academic Press New York, London
1982, editor J. Everese, B. Anderson, K. You, chapter 4. However, most of
these
derivatives are not well accepted by enzymes. The only derivative that has
therefore
been used up to now for diagnostic tests is 3-acetylpyridine adenine
dinucleotide
(acetyl-NAD) which was described for the first time in 1965 (N.O. Kaplan, J.
Biol.
Chem. (1956), 221, 823). This coenzyme also shows a poor acceptance by enzymes
and a change in the redox potential.
WO 01/94370 describes the use of further NAD derivatives with a modified
pyridine group. However, modifications of the nicotinamide group generally
have a
direct influence on the catalytic reaction. In most cases this influence is
negative.
In another stabilization concept the ribose unit was altered in order to thus
influence
the stability of the glycosyl linkage. This procedure does not directly
interfere with
the catalytic reaction of the nicotinamide group. However, it may have an
indirect
influence as soon as the enzyme exhibits a strong and specific binding to the
ribose
unit. Kaufmann et al. disclose in this connection a number of thioribose-NAD
derivatives in WO 98/33936 and US 5,801,006 and in WO 01/49247. However, a
CA 02770249 2012-02-06
- 4 -
relationship between the modification of the nicotinamide ribose unit and the
activity of the derivatives in enzymatic reactions has not been shown to date.
carbaNAD, a derivative without a glycosyl linkage was described for the first
time
in 1988 (J.T. Slama, Biochemistry (1988), 27, 183, and Biochemistry (1989),
28,
7688). The ribose therein is substituted by a carbacyclic sugar unit. Although
carbaNAD was described as a substrate for dehydrogenases, its activity has
previously not been demonstrated clinically in biochemical detection methods.
A similar approach was described later by G.M. Blackburn (Chem. Comm. (1996),
2765) in order to prepare carbaNAD with a methylene bisphosphonate compound
instead of the natural pyrophosphate. The methylene bisphosphonate shows an
increased stability towards phosphatases and was used as an inhibitor for ADP-
ribosyl cyclase. An increase in hydrolysis stability was not the aim (J.T.
Slama,
G.M. Blackburn).
WO 2007/012494 and US 11/460,366 finally disclose stabilized NAD/NADH and
NADP/NADPH derivatives, enzyme complexes of these derivatives and their use in
biochemical detection methods and reagent kits.
The underlying object of the present invention was to provide a method for
stabilizing enzymes, especially for the long-term stabilization of enzymes
which at
least partially eliminates the above-mentioned disadvantages.
This object is achieved according to the invention by a method for stabilizing
an
enzyme, wherein the enzyme is stored in the presence of a stabilized coenzyme.
It
was surprisingly found that a long-term stabilization of several weeks or
months at
high relative humidity or even in a liquid phase, at elevated temperatures and
in
ambient light is possible with the aid of a stabilized coenzyme. In this
connection
CA 02770249 2012-02-06
- 5 -
the term "storage" means that the enzyme is kept for any time period,
preferably for
a time period of at least 2 weeks, more preferably for a time period of at
least 3
months, even more preferably for a time period of at least 6 months, and most
preferably for a time period of at least 12 months in the presence of the
stabilized
coenzyme where the storage preferably takes place at atmospheric pressure,
room
temperature (25 C) and a relative air humidity of at least 50 %.
This finding is surprising because it is known that although enzymes exhibit
an
increased short-term stability of several hours in the presence of the native
coenzyme (Bertoldi et al., Biochem. J. (2005), 389, 885; van den Heuvel et
al., J.
Biol. Chem. (2005), 280, 32115; and Pan et al., J. Chin. Biochem. Soc. (1974),
3,
1), they have a lower stability over a longer period (Nutrition Reviews
(1978), 36,
251). The long-term stability of diagnostic test elements which comprise an
enzyme
and a stabilized coenzyme which has now been observed towards moisture or/and
heat is all the more surprising because stabilized coenzymes have lower
binding
constants with the enzyme than the corresponding native coenzymes.
The enzyme stabilized by the method according to the invention is a coenzyme-
dependent enzyme. Suitable enzymes are for example dehydrogenases, in
particular
dehydrogenases selected from the group consisting of an alcohol dehydrogenase
(EC 1.1.1.1.; EC 1.1.1.2), an L-amino acid dehydrogenase (EC 1.4.1.5), a
glucose
dehydrogenase (EC 1.1.1.47), a glucose-6-phosphate dehydrogenase (EC
1.1.1.49),
a glycerol dehydrogenase (EC 1.1.1.6), a 3-hydroxybutyrate dehydrogenase (EC
1.1.1.30), a lactate dehydrogenase (EC 1.1.1.27; EC 1.1.1.28), a malate
dehydrogenase (EC 1.1.1.37) and a sorbitol dehydrogenase. Further suitable
enzymes are oxidases such as e.g. glucose oxidase (EC 1.1.3.4) or cholesterol
oxidase (EC 1.1.3.6), aminotransferases such as e.g. aspartate
aminotransferase or
alanine aminotransferase, 5'-nucleotidase, creatine kinase and diaphorase (EC
1.6.99.2). The enzyme is preferably an alcohol dehydrogenase (EC 1.1.1.1; EC
CA 02770249 2012-02-06
- 6 -
1.1.1.2), a glucose dehydrogenase (EC 1.1.1.47), a glucose-6-phosphate
dehydrogenase (EC 1.1.1.49) or a diaphorase (EC 1.6.99.2).
If a glucose dehydrogenase (EC 1.1.1.47) is used as the enzyme, then a mutated
glucose dehydrogenase can for example be used within the scope of the method
according to the invention. The term "mutant" as used within the scope of the
present application refers to a genetically modified variant of a native
enzyme
which, while having the same number of amino acids, has an amino acid sequence
which is modified compared to the wild-type enzyme i.e. differs in at least
one
amino acid from the wild-type enzyme. The introduction of the mutation(s) can
take
place site-specifically or non-site-specifically, preferably site-specifically
using
recombinant methods as known in the specialized field resulting in at least
one
amino acid substitution within the amino acid sequence of the native enzyme
depending on the respective requirements and conditions. The mutant
particularly
preferably has an increased thermal or hydrolytic stability compared to the
wild-type
enzyme. Examples of such mutants are described by Baik (Appl. Environ.
Microbiol. (2005), 71, 3285), Vasquez-Figueroa (ChemBioChem. (2007), 8, 2295)
as well as in WO 2005/045016 A2 to the disclosure of which reference is
herewith
explicitly made.
The mutated glucose dehydrogenase can in principle contain the amino acid(s)
which is(are) modified compared to the corresponding wild-type glucose
dehydrogenase at any position in its amino acid sequence. The mutated glucose
dehydrogenase preferably contains a mutation in at least one of the positions
96, 170
and 252 of the amino acid sequence of the wild-type glucose dehydrogenase,
where
mutants having mutations at position 96 and position 170 or mutations at
position
170 and position 252 are particularly preferred. It has proven to be
advantageous
when the mutated glucose dehydrogenase contains no further mutations apart
from
these mutations.
CA 02770249 2012-02-06
- 7 -
The mutation at positions 96, 170 and 252 can in principle comprise any amino
acid
substitution which results in a stabilization, e.g. an increase in the thermal
or
hydrolytic stability, of the wild-type enzyme. The mutation at position 96
preferably
comprises an amino acid substitution of glutamic acid by glycine, whereas in
relation to position 170 an amino acid substitution of glutamic acid by
arginine or
lysine, in particular an amino acid substitution of glutamic acid by lysine,
is
preferred. With regard to the mutation at position 252 it preferably comprises
an
amino acid substitution of lysine by leucine.
The mutated glucose dehydrogenase can be obtained by mutation of a wild-type
glucose dehydrogenase derived from any biological source, where the term
"biological source" in the context of this invention includes both prokaryotes
such
as for example bacteria, and eukaryotes such as for example mammals and other
animals. The wild-type glucose dehydrogenase is preferably derived from a
bacterium and it is particularly preferably a glucose dehydrogenase from
Bacillus
megaterium, Bacillus subtilis or Bacillus thuringiensis, in particular from
Bacillus
subtilis.
In a particularly preferred embodiment the mutated glucose dehydrogenase is a
glucose dehydrogenase obtained by mutation of wild-type glucose dehydrogenase
from Bacillus subtilis which has the amino acid sequence shown in SEQ ID NO:1
(GlucDH E96G E170K) or that shown in SEQ ID NO:2
_
(GlucDH E170K K252L).
A stabilized coenzyme within the scope of the present invention is a coenzyme
which has been chemically modified compared to the native coenzyme and which
at
atmospheric pressure has a higher stability compared to the native coenzyme
towards moisture, temperatures especially in the range from 0 C to 50 C, acids
and
bases especially in the range from pH 4 to pH 10, or/and nucleophiles such as
for
example alcohols or amines and in this respect can exhibit its activity under
CA 02770249 2012-02-06
- 8 -
identical environmental conditions over a longer time period than the native
coenzyme. The stabilized coenzyme preferably has a higher hydrolytic stability
compared to the native coenzyme where a complete hydrolytic stability under
the
test conditions is particularly preferred. In comparison with the native
coenzyme,
the stabilized coenzyme may have a reduced binding constant for the enzyme,
for
example a binding constant reduced by a factor of two or more.
Preferred examples of stabilized coenzymes are stabilized derivatives of
nicotinamide adenine dinucleotide (NAD/NADH) or nicotinamide adenine
dinucleotide phosphate (NADP/NADPH) or shortened NAD derivatives e.g.
without the AMP moiety or with non-nucleoside residues e.g. hydrophobic
residues.
The compound of formula (I) is likewise preferred as a stabilized coenzyme in
the
sense of the present invention.
0
-----7''',------'1'''''NH2
V 0
e I I
OH
OH
HO OH
(0.
Preferred stabilized derivatives of NAD/NADH and NADP/NADPH are described
in the aforementioned references to the disclosure of which reference is
herewith
explicitly made. Particularly preferred stabilized coenzymes are described in
WO
2007/012494 and US 11/460,366 to the disclosure of which reference is herewith
explicitly made. The stabilized coenzyme is particularly preferably selected
from
compounds of the general formula (II):
CA 02770249 2012-02-06
- 9 -
A
V 1
HO 0o ' T U 2
\ A
/ X \\I
U
(II)
in which
A = adenine or an analogue thereof,
T = in each case independently 0, S,
U = in each case independently OH, SH, BH3-, BCNH2-,
V = in each case independently OH or a phosphate group, or two groups
which
form a cyclic phosphate group,
W = COOR, CON(R)2, CUR, CSN(R)2 in which R = in each case
independently
H or Ci-C2 alkyl,
Xi, X2 =in each case independently 0, CH2, CHCH3, C(CH3)2, NH, NCH3
Y= NH, S, 0, CH2,
Z = a linear or cyclic organic residue
provided that Z and the pyridine residue are not linked by a glycosidic bond,
or a
salt or optionally a reduced form thereof.
Z in the compounds of formula (II) is preferably a linear residue with 4-6 C
atoms,
preferably with 4 C atoms, in which 1 or 2 C atoms are optionally replaced by
one
or more heteroatoms selected from 0, S and N, or a residue comprising a cyclic
group with 5 or 6 C atoms which optionally contains a heteroatom selected from
0,
S and N as well as optionally one or more substituents, and a residue CR42,
where
CR42 is bound to the cyclic group and to X2, where R4 is in each case
independently
H, F, Cl, CH3.
CA 02770249 2012-02-06
- 10 -
Z is particularly preferably a saturated or unsaturated carbocyclic or
heterocyclic 5-
membered ring, in particular a compound of the general formula (III)
C(R4)2- \ R6,
\ s
RH- ______________________________________ R5'
(HI)
in which a single or double bond may be present between R5' and R5", where
R = in each case independently H, F, Cl, CH3,
R5 = CR42,
R5' = 0, S, NH, NCI-C2-alkyl, CR42, CHOH, CHOCH3, and R5" = CR42, CHOH,
CHOCH3 if there is a single bond between R5' and R5",
R5' =R5" = CR4 if there is a double bond between R5' and R5"
and
R6, R6' _ in each case independently CH or CCH3.
In a preferred embodiment the compounds according to the invention contain
adenine or adenine analogues such as e.g. C8-substituted and N6-substituted
adenine, deaza variants such as 7-deaza, aza variants such as 8-aza or
combinations
such as 7-deaza or 8-aza or carbocyclic analogues such as formycin where the 7-
deaza variants can be substituted in the 7 position by halogen, C1-C6 alkinyl,
C1-C6
alkenyl or C1-C6 alkyl.
In a further preferred embodiment the compounds of formula (II) contain
adenosine
analogues which contain for example 2-methoxydeoxyribose, 2'-
fluorodeoxyribose,
hexitol, altritol or polycyclic analogues such as bicyclo, LNA and tricyclo
sugars
instead of ribose.
CA 02770249 2014-06-30
lo a
In accordance with one aspect of the present invention there is provided a
method for stabilizing an enzyme
wherein
the enzyme is stored in the presence of a stabilized coenzyme, and an alcohol
dehydrogenase having the number EC 1.1.1.2, a glucose-6-phosphate
dehydrogenase having the number EC 1.1.1.49 or a diaphorase having the
number EC 1.6.99.2 is used as the enzyme,
wherein
the stabilized coenzyme is a stabilized nicotinamide adenine dinucleotide
(NAD/NADH) compound, a stabilized nicotinamide adenine dinucleotide
phosphate (NADP/NADPH) compound or a compound of formula (I)
0
N H2
0 I OH
OH
HO OH
(I)
In accordance with another aspect of the present invention there is provided a
enzyme
which is stabilized with a stabilized coenzyme
wherein
the enzyme exhibits a decrease in enzyme activity of less than 50 %, based on
the
initial value of enzyme activity when stored for at least 2 weeks, at a
temperature of
at least 20 C, or in the presence of light at a wavelength of? 300 nm,
optionally at
high air humidity or in the absence of desiccants, wherein the enzyme is an
alcohol
dehydrogenase having the number EC 1.1.1.2, a glucose-6-phosphate
dehydrogenase
having the number EC 1.1.1.49 or a diaphorase having the number EC 1.6.99.2,
wherein
CA 02770249 2014-06-30
10b
the stabilized coenzyme is a stabilized nicotinamide adenine dinucleotide
(NAD/NADH) compound, a stabilized nicotinamide adenine dinucleotide phosphate
(NADP/NADPH) compound or a compound of formula (I)
0
I NH2
0
0 OH
OH
HO OH
(I)
In accordance with a further aspect of the present invention there is provided
a
method for stabilizing an enzyme
wherein
the enzyme is stored in the presence of a native coenzyme, where a
dehydrogenase
selected from the group consisting of an alcohol dehydrogenase having the
number
EC 1.1.1.1 or EC 1.1.1.2, an L-amino acid dehydrogenase having the number EC
1.4.1.5, a glucose dehydrogenase having the number EC 1.1.1.47, a glucose-6-
phosphate dehydrogenase having the number EC 1.1.1.49, a glycerol
dehydrogenase
having the number EC 1.1.1.6, a 3-hydroxybutyrate dehydrogenase having the
number EC 1.1.1.30, a lactate dehydrogenase having the number EC 1.1.1.27 or
EC
1.1.1.28, and a malate dehydrogenase having the number EC 1.1.1.37, or a
diaphorase having the number EC 1.6.99.2 is used as the enzyme
wherein
the native coenzyme is a native nicotinamide adenine dinucleotide (NAD/NADH)
compound or a native nicotinamide adenine dinucleotide phosphate
(NADP/NADPH) compound.
CA 02770249 2012-02-06
- 11 -
In particular (di)-phosphate oxygens can also be isotronically replaced in the
compounds of formula (II) such as for example 0" by S- or BH3-, 0 by NH, NCH3
or
CH2 and =0 by =S. W in the compounds of formula (II) according to the
invention
is preferably CONH2 or C0CH3.
R5 in the groups of formula (III) is preferably CH2. Furthermore, it is
preferred that
R5' is selected from CH2, CHOH and NH. In a particularly preferred embodiment
R5'
and R5" are each CHOH. In yet a further preferred embodiment R5' is NH and R5"
is
CH2. A compound of formula (III) in which R4 = H, R5 = CH2, R5' = R5" = CHOH
and R6 = R6' = CH is more preferred. Specific examples of preferred stabilized
coenzymes are shown in figures lA and 1B. In the most preferred embodiment the
stabilized coenzyme is the compound carbaNAD
The method according to the invention is especially suitable for the long-term
stabilization of enzymes. This means that the stabilized enzyme is stored e.g.
as a
dry substance or in a liquid phase, for example over a period of at least 2
weeks,
preferably of at least 4 weeks and most preferably of at least 8 weeks during
which
the enzyme activity decreases preferably by less than 50 %, more preferably by
less
than 30 %, and most preferably by less than 20 % based on the initial value of
the
enzyme activity.
The method according to the invention additionally comprises a storage of the
stabilized enzyme at elevated temperatures, for example at a temperature of at
least
20 C, preferably of at least 25 C and most preferably of at least 30 C during
which
the enzyme activity decreases preferably by less than 50 %, more preferably by
less
than 30 % and most preferably by less than 20 % based on the initial value of
the
enzyme activity. The storage can, if necessary, be carried out for a longer
period as
stated above.
CA 02770249 2012-02-06
- 12 -
Moreover, the method according to the invention envisages a storage of the
stabilized enzyme in the presence of ambient light i.e. in the presence of
light at a
wavelength of > 300 nm, during which the enzyme activity preferably decreases
by
less than 50 %, more preferably by less than 30 % and most preferably by less
than
20 % based on the initial value of the enzyme activity. In this case the
storage can, if
necessary, be carried out for a longer period or/and at elevated temperatures
as
stated above. Due to the stability of the enzyme system towards ambient light,
the
stabilized enzyme can in addition also be exposed to direct sunlight shortly
before
use or/and after removal from a package.
The stabilization according to the invention also enables the stabilized
enzyme to be
stored without a desiccant or/and at a high relative air humidity e.g. at a
relative air
humidity of at least 50 %, during which the enzyme activity decreases by less
than
50 %, more preferably by less than 30 % and most preferably by less than 20 %
based on the initial value of the enzyme activity. In this case the storage
can, if
necessary, be carried out for a longer period, at elevated temperatures or/and
in the
presence of ambient light as stated above. Methods or tests for determining
the
activity of enzymes are widely known in the prior art and, if required, can be
adapted by a person skilled in the art to the respective requirements where
the same
test conditions are used in each case to compare the enzyme activity before
and after
storage.
The stabilized enzyme can be stored on the one hand as a dry substance and, on
the
other hand, in a liquid phase. The stabilized enzyme is preferably stored on
or in a
test element that is suitable for determining an analyte. In this case the
stabilized
enzyme is preferably a component of a detection reagent which can optionally
contain other components such as mediators, optical indicators, salts, buffers
etc.
The stabilized enzyme can be used to detect analytes for example parameters in
body fluids, such as blood, serum, plasma or urine or in samples of sewage or
in
CA 02770249 2012-02-06
- 13 -
foods. Any biological or chemical substances that can be detected by a redox
reaction can be determined as analytes e.g. substances that are substrates of
a
coenzyme-dependent enzyme or coenzyme-dependent enzymes themselves.
Preferred examples of analytes are glucose, lactic acid, malic acid, glycerol,
alcohol,
cholesterol, triglycerides, ascorbic acid, cysteine, glutathione, peptides,
urea,
ammonium, salicylate, pyruvate, 5'-nucleotidase, creatine kinase (CK), lactate
dehydrogenase (LDH), carbon dioxide etc. The analyte is preferably glucose.
Another subject matter of the present invention is the use of a compound
according
to the invention or of an enzyme stabilized according to the invention to
detect an
analyte in a sample by means of an enzymatic reaction. This is particularly
preferably the detection of glucose with the aid of a glucose dehydrogenase
(EC
1.1.1.47) or a glucose-6-phosphate dehydrogenase (EC 1.1.1.49) using suitable
coenzymes.
The change in the stabilized coenzyme caused by reaction with the analyte can
in
principle be detected in any way. In this case it is in principle possible to
utilize all
methods known from the prior art for detecting enzymatic reactions. However,
the
change in the coenzyme is preferably detected by optical methods. Optical
detection
methods comprise for example the measurement of absorption, fluorescence,
circular dichroism (CD), optical rotation dispersion (ORD), refractometry.
Optical detection methods which are preferably used within the scope of the
present
application are photometry and fluorimetry. In order to photometrically
measure a
change in the coenzyme due to reaction with the analyte it is, however,
additionally
necessary for at least one mediator to be present which increases the
reactivity of the
reduced coenzyme and enables electrons to be transferred to a suitable optical
indicator or an optical indicator system.
CA 02770249 2012-02-06
- 14 -
Mediators which are suitable for the purposes of the present invention include
among others nitrosoanilines such as for example [(4-nitrosophenyl)imino]-
dimethanol hydrochloride, quinones such as for example phenanthrene quinones,
phenanthroline quinones or benzo[h]-quinoline quinones, phenazines such as 1-
(3-
carboxypropoxy)-5-ethylene phenazinium trifluoromethane sulfonate or/and
diaphorase (EC 1.6.99.2).
Diaphorases, especially when compared with phenazines, have the advantage of a
higher stability, but their function can be impaired by degradation products
of native
coenzymes e.g. by degradation products of NAD or NADP as known for example
from DE 2 061 984 A.
Preferred examples of phenanthroline quinones within the sense of the present
invention comprise 1,10-phenanthroline-5,6-quinones, 1,7-phenanthroline-5,6-
quinones, 4,7-phenanthroline-5,6-quinones as well as N-alkylated and N,N'-
dialkylated salts thereof, where in the case of N-alkylated or N,N1-
dialkylated salts,
halogenides, trifluoromethane sulfonate or other anions that increase the
solubility
are preferred as the counterion. Diaphorases which are particularly suitable
for the
purposes of the present invention comprise for example diaphorase from porcine
heart, Clostridium kluyverii and Bacillus stearothermophilus as well as the
diaphorase mutant described in US 2007/0196899A1, which have an improved
catalytic function and thermostability compared to native diaphorases.
Reference is
herewith explicitly made to the disclosure of the above US application.
Any substance which is reducible and undergoes a detectable change in its
optical
properties such as for example colour, fluorescence, reflectance,
transmission,
polarization or/and refractive index can be used as an optical indicator or as
an
optical indicator system. The determination of the presence or/and the amount
of the
analyte in the sample can be carried out with the naked eye or/and by means of
a
detection device using a photometric method that appears suitable to a person
CA 02770249 2012-02-06
- 15 -
skilled in the art. Heteropoly acids and in particular 2,18-phosphomolybdic
acid are
preferably used as optical indicators which are reduced to the corresponding
heteropoly blue. Alternatively it is also possible to use quinones such as for
example
resazurine, dichlorophenol indophenol or/and tetrazolium salts as optical
indicators.
Tetrazolium salts which are particularly suitable for the purpose of the
present
invention comprise for example the commercially available products WST-3, WST-
4 and WST-5 (all from the Dojindo Company) but are, however, not limited to
these.
The change in the coenzyme is particularly preferably detected by measuring
the
fluorescence. Fluorescence measurement is highly sensitive and enables even
low
concentrations of the analyte to be detected in miniaturized systems.
Alternatively
the change in the coenzyme can also be detected electrochemically using a
suitable
test element such as for example an electrochemical test strip. The
precondition for
this is once again the use of suitable mediators which can be converted by the
reduced coenzyme into a reduced form by transfer of electrons. The analyte is
determined by measuring the current which is needed to reoxidize the reduced
mediator which correlates with the concentration of the analyte in the sample.
Examples of mediators which can be used for electrochemical measurements
comprise in particular the aforementioned mediators used for photometric
measurements.
It is possible to use a liquid test to detect an analyte where the reagent is
for
example present in the form of a solution or suspension in an aqueous or non-
aqueous liquid, or as a powder or lyophilisate. However, it is also possible
to use a
dry test where the reagent is applied to a support. The support can for
example be a
test strip comprising an absorbent or/and swellable material which is wetted
by the
sample liquid to be investigated.
CA 02770249 2012-02-06
- 16 -
A particularly preferred test format comprises the use of the enzyme glucose-6-
phosphate dehydrogenase with a stabilized NAD derivative for the detection of
glucose especially in a wet test in which case a derivative of the reduced
coenzyme
NADH is formed. NADH is detected by optical methods e.g. by photometric or
fluorometric determination after UV excitation. A particularly preferred test
system
is described in US 2005/0214891 to which reference is herewith explicitly
made.
A further aspect of the invention concerns an enzyme stabilized with a
stabilized
coenzyme where the stabilized enzyme exhibits a decrease in enzyme activity of
less than 50 %, preferably of less than 30 % and most preferably of less than
20 %
based on the initial value of enzyme activity when stored for at least 2
weeks,
preferably for at least 4 weeks and most preferably for at least 8 weeks at a
temperature of at least 20 C, preferably of at least 25 C and most preferably
of at
least 30 C or/and in the presence of light at a wavelength of > 300 nm, where
appropriate at high air humidity or/and in the absence of desiccants. In this
case an
enzyme is used as stated above.
Yet a further aspect of the invention concerns a detection reagent for
determining an
analyte which contains a stabilized enzyme as stated above. In addition the
invention concerns a test element which contains an enzyme stabilized
according to
the invention or a detection reagent according to the invention. The detection
reagent and the test element may be suitable for carrying out dry tests or
liquid tests.
The test element is preferably a test strip for the fluorometric or
photometric
detection of an analyte. Such a test strip contains the stabilized enzyme in
an
immobilized form on an absorbent or/and swellable material such as cellulose,
plastic etc.
Yet a further aspect of the invention concerns a method for stabilizing an
enzyme
especially towards ambient light, wherein the enzyme as previously specified,
is
stored in the presence of a native coenzyme. In a preferred variant an alcohol
CA 02770249 2012-02-06
- 17 -
dehydrogenase (EC 1.1.1.1; EC 1.1.1.2), a glucose dehydrogenase (EC 1.1.1.47),
a
glucose-6-phosphate dehydrogenase (EC 1.1.1.49) or a diaphorase (EC 1.6.99.2)
is
used as the enzyme, where glucose dehydrogenases (EC 1.1.1.47) comprising
native
and mutated glucose dehydrogenases, and glucose-6-phosphate dehydrogenases (EC
1.1.1.49) are particularly preferred. A native nicotinamide adenine
dinucleotide
(NAD/NADH) or a native nicotinamide adenine dinucleotide phosphate
(NADP/NADPH) compound and in particular native NAD or NADP is preferably
used as the native coenzyme.
It is intended to elucidate the invention in more detail on the basis of the
following
figures and examples.
Description of the figures
Figure 1A: Diagram of the stabilized coenzyme carbaNAD (cNAD).
Figure 1B: Diagram of the stabilized coenzyme pyrrolidinyl NAD.
Figure 2: Diagram of the results of the enzyme kinetics of glucose
dehydrogenase
in the presence of NAD and of glucose dehydrogenase in the presence of cNAD
before and after storage.
2A: Kinetics of GlucDH in the presence of NAD after 1 day.
2B: Kinetics of GlucDH in the presence of cNAD after 1 day.
2C: Kinetics of GlucDH in the presence of NAD after 5 weeks storage at 32 C
and
85 % relative air humidity.
2D: Kinetics of GlucDH in the presence of cNAD after 5 weeks storage at 32 C
and
85 % relative air humidity.
CA 02770249 2012-02-06
- 18 -
Figure 3: Comparison of the blank values of glucose dehydrogenase in the
presence
of NAD or of GlucDH in the presence of cNAD over a period of up to 5 weeks at
32 C and 85 % air humidity.
Figure 4: Diagram of various function curves of glucose dehydrogenase after
storage of glucose dehydrogenase in the presence of NAD at 32 C and 85 % air
humidity. The storage period varied between 1 day and 5 weeks.
Figure 5: Diagram of various function curves of glucose dehydrogenase after
storage of glucose dehydrogenase in the presence of cDNA at 32 C and 85 % air
humidity. The storage period varied between 1 day and 5 weeks (figure 5A) and
between 1 day and 24 weeks (figure 5B).
Figure 6: Diagram of the residual content of NAD or cNAD after storage of
glucose
dehydrogenase in the presence of NAD or cNAD respectively for 24 weeks at 32 C
and 85 % air humidity.
Figure 7: Diagram of the GlucDH activity after storage of glucose
dehydrogenase
in the presence of NAD or cNAD for 5 weeks (figure 7A) or 24 weeks (figure 7B)
at
32 C and 85 % air humidity.
Figure 8: Diagram of the GlucDH activity after storage of glucose
dehydrogenase
(GlucDH-wt), the double mutant GlucDH E96G E170K (GlucDH-Mutl) and the
_
double mutant GlucDH E170K_ K252L (G1ucDG-Mut2) for a period of 25 weeks
_
in the presence of NAD or cNAD at 32 C and 83 % relative air humidity.
Figure 9: Diagram of the stability of glucose dehydrogenase in the presence of
NAD or cNAD in a liquid phase at 50 C for a period of 4 days (figure 9A) or 14
CA 02770249 2012-02-06
- 19 -
days (figure 9B). Test conditions: 10 mg/ml GlucDH; 12 mg/ml NAD or cNAD;
buffer: 0.1 M Tris, 1.2 M NaCI, pH 8.5; temperature 50 C.
Figure 10: Diagram of various function curves of alcohol dehydrogenase in the
presence of cNAD. The concentration of cNAD varied between 25 % and 150 %
based on the initial concentration of NAD in the liquid test.
Figure 11: Diagram of the results of the enzyme kinetics of alcohol
dehydrogenase
in the presence of cNAD at various ethanol concentrations.
Figure 12: Diagram of the stability of alcohol dehydrogenase from yeast in the
presence of NAD or cNAD in a liquid phase at 35 C for a period of 65 hours.
Test
conditions: 5 mg/ml ADH; 50 mg/ml NAD or cNAD; buffer: 75 mM Na4P207;
glycine, pH 9.0; temperature 35 C.
Figure 13: Diagram of various function curves of glucose dehydrogenase after
11
weeks storage in the presence of NAD and different mediators at room
temperature.
Figure 14: Diagram of the results of the enzyme kinetics of glucose
dehydrogenase
in the presence of NAD and 1-(3-carboxypropoxy)-5-ethylphenazinium-
trifluoromethane sulfonate at various glucose concentrations.
Figure 15: Schematic representation of the glucose detection using GlucDH as
the
enzyme and diaphorase as the mediator.
Figure 16: Diagram of the function curves of glucose-dye-oxidoreductase
(GlucDOR) in the presence of pyrroloquinoline quinone (PQQ) and [(4-
nitrosophenyl)imino]dimethanol hydrochloride as the mediator and of glucose
CA 02770249 2012-02-06
- 20 -
dehydrogenase in the presence of NAD and diaphorase / [(4-nitrosophenyeiminol-
dimethanol hydrochloride as the mediator.
Figure 17: Diagram of the results of the enzyme kinetics of glucose
dehydrogenase
in the presence of NAD and diaphorase at various glucose concentrations.
Figure 18: Diagram of the current measured as a function of the glucose
concentration in the electrochemical determination of glucose using glucose
dehydrogenase in the presence of NAD or cNAD. Test conditions: 25 mM NAD or
cNAD; 2.5 seconds delay; 5 seconds measurement time.
Figure 19: Diagram of various function curves of glucose dehydrogenase in the
presence of NAD after irradiation by UV light at a wavelength of 360 nm.
Figure 20: Diagram of the absorption spectrum of cNAD and cNADH in the
wavelength range of 250-450 nm.
Figure 21: Diagram of the amino acid sequences of the glucose dehydrogenase
double mutants GlucDH E96G E170K and GlucDH E 170K K252L.
_ _ _
Example 1
carbaNAD (fig. 1A) or NAD were added to the glucose-specific GlucDH. These
formulations were each applied to Pokalon foils (Lonza) and, after drying,
stored
under warm and humid conditions (32 C, 85 % relative air humidity).
Subsequently
the reaction kinetics and the function curve were determined at regular
intervals. In
parallel at each of the measurement times a cNAD/NAD analysis and a
determination of the residual activity of the enzyme were carried out.
CA 02770249 2012-02-06
-21 -
The kinetics curves for NAD (figure 2A) and cNAD (figure 2B) determined on the
first day are comparable and also show a similar increase in the glucose
dependency. However, a significant difference in the kinetics curves can be
seen
after 5 weeks. Whereas there is a major decrease in the dynamic range of the
kinetics for NAD (figure 2C), the kinetics of the enzyme stabilized with cNAD
remains virtually unchanged (figure 2D).
There is also a considerable difference in the blank values (dry blank value
before
application of a blood sample) as shown in figure 3. The increase in the dry
blank
value for NAD is due to the formation of fluorescent particles (Oppenheimer
(1982), Supra). Surprisingly this does not occur with cNAD.
The different stability of glucose dehydrogenase in the presence of NAD or
cNAD
is also evident from a comparison of figures 4 and 5. After 5 weeks the
function
curve for the enzyme stabilized with cNAD still lies within the set of curves
of the
previous measurements (figure 5A), whereas the curve for the enzyme treated
with
NAD (figure 4) shows a fall-off at higher concentrations which is a typical
sign for
inadequate amounts of enzyme / coenzyme. Figure 5B shows various function
curves of the glucose dehydrogenase stabilized with cNAD over a period of 24
weeks. In this connection it is clear that the function of the enzyme is only
slightly
changed at high glucose concentrations over the entire period and
approximately
corresponds after 24 weeks to the value obtained after 5 weeks.
The relation between the structure of the coenzyme and its stability over a
predetermined period is shown in figure 6. According to this the residual
content of
cNAD in a glucose detection reagent is still about 80 % of the initial value
after 24
weeks storage (at 32 C and 85 % relative air humidity), whereas the content of
NAD in a glucose detection reagent stabilized with NAD is already reduced to
about
% of the initial value after 5 weeks and, by extrapolation, is reduced to zero
after
about 17 weeks.
CA 02770249 2012-02-06
- 22 -
The result of the determination of residual activity of the active enzyme
GlucDH
after 5 weeks at 32 C and 85 % relative air humidity (figure 7A) is completely
surprising. The enzyme stabilized with NAD now only has an extremely low
enzyme activity (0.5 %), whereas the enzyme stabilized with cNAD still has a
residual activity of 70 % (in each case compared to the samples stored in a
refrigerator (KS) with desiccant (TM)). After 24 weeks at 32 C and 85 %
relative
air humidity (figure 7B) the residual activity of the enzyme when stabilized
with
cNAD is still about 25 %.
If a mutant is used instead of the wild-type enzyme (from Bacillus subtilis),
it is
possible to further increase the residual activity of GlucDH. After 24 weeks
storage
at 32 C and 85 % relative air humidity in the presence of cNAD the residual
activity
of a mutant GlucDH E96G_ E170K with the amino acid substitutions glutamic acid
_
¨> glycine at position 96 and glutamic acid ¨> lysine at position 170 (GlucDH-
mut 1) of the wild-type enzyme is about 70 %, whereas the residual activity of
a
mutant GlucDH _E170K K252L with the amino acid substitutions glutamic acid ¨>
lysine at position 170 and lysine ¨> leucine at position 252 (GlucDH-mut2) is
about
50 % (figure 8).
Storage of glucose dehydrogenase in a liquid phase also clearly shows the
difference
between NAD and cNAD (figures 9A and 9B). After 95 hours at 50 C the residual
activity of glucose dehydrogenase in the presence of the native coenzyme NAD
is
5 %, whereas the residual activity of GlucDH in the presence of the artificial
coenzyme cNAD is 75 % (figure 9A). After 336 hours storage at 50 C the
residual
activity of the enzyme stabilized with NAD is now only about 1 %; a residual
activity of still about 70 % is observed for the enzyme stored in the presence
of
cNAD. The corresponding SDS gels also show a change in the GlucDH bands in the
presence of the native coenzyme NAD: new bands are seen at higher molar masses
and there is a shift in the 30 kDa band.
CA 02770249 2012-02-06
- 23 -
Overall it is an extremely surprising result that the stabilization of the
cofactor
simultaneously brings about a stabilization of the enzyme - and not just
through the
cooperative effect of the better cohesion of the enzyme. Decomposition of the
cofactor NAD has an adverse effect on the stability of the enzyme GlucDH and
even
accelerates its inactivation. Replacement of native NAD by artificial
analogues
allows GlucDH to be stored under stress conditions (e.g. elevated
temperatures)
even in the presence of a cofactor.
It is possible with such a system to produce blood glucose test strips with
considerably improved stability properties for which a presentation without
desiccant is possible.
Example 2
cNAD or NAD was added to a detection solution containing alcohol
dehydrogenase.
These mixtures were stored at 2 - 8 C and at 35 C. Subsequently the stability
of
alcohol dehydrogenase (ADH) was checked at regular intervals and the residual
activity of the enzyme was determined.
Figure 10 shows the linearity of the conversion of ethanol by means of alcohol
dehydrogenase (ADH) in the presence of various concentrations of cNAD which
demonstrates the practical usability of the enzyme system ADH/cNAD to
determine
ethanol. Moreover, the kinetics curves of the conversion of ethanol by means
of a
combination of alcohol dehydrogenase and cNAD show that there is a
considerable
dependency on the concentration of the substrate where the rate of conversion
increases with increasing ethanol concentrations (figure 11).
Again storage in a liquid phase shows the difference between storage in the
presence of NAD or cNAD (figure 12). The residual activity of alcohol
CA 02770249 2012-02-06
- 24 -
dehydrogenase in the presence of the native coenzyme NAD is at about 6 % after
65
hours at 35 C, whereas the residual activity of the enzyme in the presence of
the
artificial coenzyme cNAD is still at about 60 %.
If alcohol dehydrogenase is stored together with native NAD or with cNAD for
several months at 2 - 8 C in a refrigerator, then one observes in the case of
cNAD a
considerable decrease in enzyme activity over the entire storage period.
Whereas the
difference after 2 weeks storage is still slight, there is an approximately 20
% higher
residual activity of alcohol dehydrogenase after 12 months storage in the
presence
of 16 mM cNAD compared to a corresponding solution containing 16 mM NAD as
the coenzyme. The results are shown in table 1.
Table 1
ingredient concentr. U/ml % of 2 3 7.5 10 12
(mmo1/1) (initial weighed weeks months months months months
value) amount at 2- at 2- at 2- at 2-
at 2-
(initial 8 C (% 8 C (% 8 C (% 8 C (% 8 C (%
value) of of of of of
initial initial initial initial
initial
value) value) value) value)
value)
comparable 16 142.2 85.2 96.9 92.1 80.2 70.3
60.5
mixture (NAD)
exchange 16 120.2 71.9 100.7 91.3 95.6 88.2
83.8
NAD/cNAD
The extent of the stabilization in relation to the amount of cNAD used is
shown in
table 2. Accordingly the residual activity of alcohol dehydrogenase can be
increased
somewhat in samples that have been stored for 2 weeks at 2 - 8 C by increasing
the
concentration of cNAD. In the stress model, which envisages a storage of the
enzyme for 2 weeks at 35 C, the decrease of the enzyme activity of alcohol
dehydrogenase can, however, be significantly increased by increasing
concentrations of cNAD and in the case of a concentration of 15 mM to cNAD an
CA 02770249 2012-02-06
- 25 -
approximately 45 % higher residual activity is observed compared to a solution
of
the enzyme in the presence of 0.5 mM cNAD.
Table 2
Sample pH /additive U/ml % of weighed 2 weeks at 2- 2 weeks
at
(initial value) amount 8 C (% of 35 C (% of
(initial value) initial value) initial
value)
1 pH 7.85 123.1 73.7 93.8 31.1
0.5 mM cNAD
2 pH 7.85 125.8 75.3 97.7 45.5
1 mM cNAD
3 pH 7.85 125.1 74.9 101.1 74.1
mM cNAD
4 pH 7.85 123.7 74.1 104.0 77.6
mM cNAD
5 Example 3
Various test systems which each contained glucose dehydrogenase, NAD, a
mediator and, where appropriate, an optical indicator were measured
photometrically and electrochemically in order to determine glucose.
For photometric measurements four test elements which had each been stored for
11
10 weeks at room temperature and contained 2,18-phosphomolybdic acid in
addition to
glucose dehydrogenase, NAD and a mediator, were initially investigated at
various
glucose concentrations.
As shown in figure 13, a decrease in the reflectance was observed with
increasing
glucose concentrations for all four mediators that were used i.e. [(4-nitroso-
15 phenyl)imino]dimethanol hydrochloride (med A), 1-methy1-5,6-dioxo-5,6-
dihydro-
1,10-phenanthrolinium-trifluoromethane sulfonate (med B), 7-methy1-5,6-dioxo-
5,6-dihydro-1,7-phenanthrolinium-trifluoromethane sulfonate (med F) and 1-(3-
CA 02770249 2012-02-06
- 26 -
carboxy-propoxy)-5-ethylphenazinium-trifluoromethane sulfonate (med G) and
thus
the above-mentioned mediators are in principle suitable for determining
glucose by
means of photometry.
At high glucose concentrations in the region of 800 mg/d1 the reflectance of
the
measured sample is still about 20 % when using [(4-nitrosophenyl)imino]di-
methanol hydrochloride or 1-(3-carboxypropoxy)-5-ethylphenazinium-
trifluoromethane sulfonate suggesting that these two mediators are
particularly
suitable for photometric measurements using the glucose dehydrogenase / NAD
system, and thus also the glucose dehydrogenase / cNAD system. The kinetics of
the
conversion of glucose using the system glucose dehydrogenase, NAD, 1-(3-
carboxypropoxy)-5-ethylphenazinium-trifluoromethane sulfonate and 2,18-
phosphomolybdic acid at glucose concentrations in the range from 0 to 800
mg/di is
shown in figure 14.
The schematic representation in figure 15 shows that the photometric
determination
of glucose can also take place with the (additional) use of diaphorase as an
intermediary mediator. Figure 16 shows a concentration-dependent decrease in
reflectance for the glucose dehydrogenase, NAD, diaphorase, [(4-nitrosopheny1)-
imino]dimethanol hydrochloride and 2,18-phosphomolybdic acid system (system
1).
The glucose-dye-oxidoreductase, pyrroloquinoline quinone, [(4-nitroso-
phenyl)imino]dimethanol hydrochloride and 2,18-phosphomolybdic acid system
(system 2) served as a comparison which likewise causes a concentration-
dependent
decrease in the reflectance but has disadvantages because of the low
specificity of
glucose-dye-oxidoreductase. The kinetics of the conversion of glucose using
system
1 is shown in figure 17 for glucose concentrations in the range from 0 to 800
mg/d1.
As an alternative to photometry, an electrochemical measurement can also be
used
for the purposes of determining analytes. Thus, the current required to
reoxidize the
reduced mediator was found to be linearly dependent on the glucose
concentration
CA 02770249 2012-02-06
- 27 -
(figure 18) both for a test element which besides glucose dehydrogenase,
contained
NAD as a coenzyme and 1-(3-carboxypropoxy)-5-ethylphenazinium-
trifluoromethane sulfonate as a mediator, and for a corresponding system which
contained the stabilized coenzyme cNAD instead of NAD.
It has thus been shown that the analyte determination can be carried out using
the
dehydrogenase / stabilized coenzyme system as well as by means of
electrochemical
detection and evaluation at another wavelength which is independent of the
coenzyme. The overall formulation should also be further stabilized by the use
of
the stabilized enzyme / coenzyme pair.
Example 4
In order to determine their stability towards ambient light, various test
systems
which each contained an enzyme selected from glucose dehydrogenase (GlucDH),
glucose-6-phosphate dehydrogenase (G6PDH) and glucose dehydrogenase mutant 2
(GlucDH-mut2) in combination with NAD or carbaNAD were prepared in
accordance with the methods described in WO 03/097859 A2 and subsequently a
blood sample was added. In particular the test systems were prepared by
applying a
photopolymerizable liquid composition comprising an enzyme and coenzyme to a
support and subsequently irradiating the composition with light at a
wavelength of
360 nm and 400 W for 10 seconds to obtain reagent layers having a thickness of
12
- 15 ,m. Detection was carried out in the fluorescence mode for a period of
several
minutes.
Figure 19 shows the results of the measurements for the GlucDH/NAD system. As
shown by the graph no reduction of fluorescence whatsoever was observed over
the
entire measurement period which allows the conclusion that even irradiation of
the
reagent layer lasting several minutes with energy-rich radiation does not
impair the
reagent layer due to the lack of absorption of the GlucDH/NAD system in the
region
CA 02770249 2012-02-06
- 28 -
> 300 nm. Taking into consideration the fact that the G6PDH/NAD system and the
carbaNAD-containing systems GlucDH/carbaNAD, G6PDH/carbaNAD and
G1ucDH-mut2/carbaNAD do not absorb in the wavelength region > 300 nm (figure
20), all these systems also have a high stability towards ambient light
(results not
shown).
Example 5
Specific examples of compositions that can be used to produce the diagnostic
test
elements described herein are specified in the following.
a) Liquid reagent for determining the activity of lactate dehydrogenase
A liquid reagent which, among others, contained diaphorase, carbaNAD, a
tetrazolium salt and lactate was used to determine the activity of lactate
dehydrogenase. The detection reagent which was stored in solution at 25 C
contained the following ingredients:
3 U/ml diaphorase (from porcine heart)
2 mM carbaNAD or 0.2 mM NAD
2 mM tetrazolium salt WST-3
50 mM Na lactate
0.1 M tricine/HC1, pH 8.8
A measurement of the activity of diaphorase at various storage times showed a
considerably increased residual activity of the formulation containing
carbaNAD
compared to a corresponding formulation containing NAD as the coenzyme.
CA 02770249 2012-02-06
- 29 -
b) Test strips for the determination of blood glucose
A composition which, among others, contained glucose dehydrogenase (GlucDH),
carbaNAD, diaphorase, nitrosoaniline and phosphomolybdic acid was used to
determine blood glucose. Test strips were obtained by applying a first
formulation
to a polycarbonate foil using a doctor blade (layer height 100 Jim), drying
the first
layer, applying a second formulation to the first layer (doctor blade gap 30
[tm), and
drying the second layer and they were stored at 32 C and 30 - 70 % relative
air
humidity. The formulations used for the first and second layer are shown in
table 3:
Table 3
Ingredients 1st layer 2nd layer
xanthan gum 0.09 g
sodium aluminium silicate 5.00 g
polyvinyl propionate dispersion 4.80 g 5.80 g
(50 % by weight in water)
methyl vinyl ether-maleic acid copolymer 1.40 g
titanium dioxide 14.00 g
NaOH 16 % 2.80g
silicic acid 2.50 g
phosphate buffer 0.1 M 13.80g 4.40g
N-octanoyl-N-methyl-glucamide 0.17 g 0.34 g
Na-methyl oleyl taurate 0.03 g 0.03 g
polyvinyl pyrrolidone (MW 25000) 0.85 g 1.80 g
tetraethylammonium chloride 0.12 g
Bis-(2-hydroxyethyl)-(4- 0.10 g
hydroxyiminocyclohexa-2,5-dienylidine)-
ammonium chloride
2,18-phosphomolybdic acid, hexasodium salt 0.50 g
NaC1 1.00 g
carbaNAD (or NAD) 1.00 g
(0.10 g)
Diaphorase 1.94 g (203 KU)
glucose dehydrogenase 0.97 g (207 KU)
Hexanol 0.17g 0.16g
2-methoxy-propanol 4.30 g 4.30 g
CA 02770249 2012-02-06
- 30 -
The activity of diaphorase was measured at various storage times by extracting
the
enzyme from the test strip and in the case of the formulation containing
carbaNAD
a considerably increased residual activity was observed compared to the
formulation
containing NAD.
c) Test strips for the determination of triglycerides
A composition which, among others, contained glycerol dehydrogenase, carbaNAD,
diaphorase and a tetrazolium salt was used to determine triglycerides. Test
strips
were obtained by applying the formulation mentioned in table 4 to a
polycarbonate
foil by means of a doctor blade (layer height 80 um) and subsequent drying,
and
they were stored at 32 C and 30 - 70 % relative air humidity.
Table 4
Ingredients Amount
xanthan gum 0.30 g
silicic acid (Aerosil) 5.00 g
polyvinylproprionate dispersion 6.00 g
(50 % by weight in water)
titanium dioxide 18.00 g
N-octanoyl-N-methyl-glucamide 0.20 g
polyvinyl pyrrolidone (MW 25000) 0.40 g
Tricine 0.30 g
HC1 ad pH 8.5
lipase (porcine pancreas), 12 KU/g 5.00 g
glycerol dehydrogenase, 100 U/mg 1.00 g
carbaNAD 1.60 g
(or NAD) (0.20 g)
diaphorase, 20 U/mg 2.00 g
WST-5 2.00 g
Water 82.00 g
The activity of diaphorase was measured at various storage times by extracting
the
enzyme from the test strip and in the case of the formulation containing
carbaNAD
CA 02770249 2012-02-06
-31 -
a considerably increased residual activity was observed compared to the
formulation
containing NAD.
Example 6
In order to evaluate the stabilization of glucose dehydrogenase and diaphorase
by
carbaNAD, a number of test strips were prepared in analogy to example 5. The
formulations used for the first and the second layer of the test strip are
shown in
table 5.
Table 5
Ingredients 1st layer 1st layer 2nd layer
xanthan gum 0.29 g 0.29 g
Gantrez S97 1.44 g
tetraethylammonium chloride 0.07 g 0.07 g 0.45 g
Mega 8 0.17g 0.17g 0.36g
Geropon T77 0.03 g 0.03 g 0.03 g
polyvinyl pyrrolidone (MW 25000) 0.87 g 0.87 g 1.99 g
Transpafill 4.82g 4.82g
(or silicic acid) (4.79 g) (4.79 g)
silicic acid 16.02 g
titanium dioxide 2.18 g
Propiofan 5.04g 5.02g 6.14g
N,N-bis-(2-hydroxyethyl)-4- 0.10 g 0.10 g 0.16 g
nitrosoaniline
2,18-phosphomolybdic acid, 0.33 g 0.33 g 1.98 g
hexasodium salt
K/Na buffer 0.1 M 10.00 g 9.96g
NAD 0.58g
carbaNAD 4.00 g
glucose dehydrogenase, mutant 2 1.06 g (324 KU) 1.06 g (324 KU)
Diaphorase 0.78 g (80 KU) 1.26 g(130 KU)
K3[Fe(C1\)61 0.01 g 0.01 g 0.01 g
NaOH 16 % 0.25 g 0.28 g 2.69 g
tert. amyl alcohol 1.00 g 1.00 g 1.07 g
The test strips were stored over a period of 18 weeks at temperatures of 5 C
(KS,
refrigerator), 25 C (RT), 30 C (GT), 35 C (DT) and 45 C (HT), and the enzyme
CA 02770249 2012-02-06
- 32 -
activity in the test strips was determined at the start of storage (0 weeks),
after 6
weeks, after 9 weeks, after 12 weeks and after 18 weeks. The results are shown
in
table 6 (glucose dehydrogenase) and in table 7 (diaphorase).
Table 6
Storage Coenzyme Enzyme activity (U/cm2)
temperature 0 weeks 6 weeks 9 weeks 12
weeks 18 weeks Target
KS 16.5 16.6 14.4 13.8
RT 15.8 14.4 12.9 12.2
GT NAD 14.6 n.d. n.d. 9.7 9.1 25.4
DT 12.9 10.9 9.4 8.5
HT 7.8 6.2 n.d. n.d
KS 20.4 21.2 18.5 18.8
RT 20.7 21.5 18.0 17.7
GT carbaNAD 19.8 n.d. n.d. 17.6 16.8 25.8
DT 19.8 20.2 17.2 16.9
HT 19.0 18.8 n.d n.d
Table 7
Storage Coenzyme Enzyme activity (U/cm2)
temperature 0 weeks 6 weeks 9 weeks 12
weeks 18 weeks Target
KS 2.2 2.4 3.3 3.7
RT 2.3 2.2 2.8 3.4
GT NAD 2.7 n.d n.d. 2.4 2.8 6.3
DT 1.5 1.8 2.4 2.8
HT 1.5 1.1 n.d. n.d.
KS 4.4 5.2 4.8 7.0
RT 4.5 5.1 4.6 6.7
GT carbaNAD 4.6 n.d. n.d. 4.3 6.2 10.4
DT 3.4 4.4 4.0 5.3
HT 3.9 3.8 n.d. n.d.
As shown in tables 7 and 8, storage of glucose dehydrogenase and diaphorase in
the
presence of carbaNAD over a period of 18 weeks allows a high enzyme activity
to
be maintained while the degradation rate of the enzymes in the presence of NAD
is
considerably more pronounced.
CA 02770249 2012-02-06
- 33 -
Example 7
In order to determine the influence of NAD and carbaNAD on the thermostability
of
various dehydrogenases the enzymes (1 mg/ml) were dialysed in a first step
against
the respective measurement buffer for 20 hours at 4 C. Subsequently 3.8 mM NAD
or carbaNAD was added to the samples and the samples were kept at 4 C.
In order to determine the binding of NAD or carbaNAD to the various
dehydrogenases, a dynamic differential scanning calorimetry (DSC) was carried
out
in which the calorimetric scans were carried out at temperatures between 20 C
and
100 C and at a scan rate of 120 C/h and each sample was measured in
triplicate.
The DSC device was cleaned and calibrated according to the MicroCal handbook
before carrying out the measurements in order to ensure a correct operation.
Lysozyme (1 mg/ml) in 0.1 M glycine-HC1 pH 2.4 was measured in duplicate as a
control before and after each scan process. Measuring cells, valve and syringe
were
washed three times with water after every six injections. The data were
analysed
using the MicroClas Origin software.
Glucose dehydrogenase mutant2 in Tris buffer, pH 8.0 led to well-defined peaks
in
the absence as well as in the presence of NAD and the melting point (TM) was
79.1 C in the absence of NAD and 80.8 C in the presence of NAD. Thus, the
binding of the glucose dehydrogenase mutant2 to NAD resulted in a TM shift of
more than 1.5 C. With the exception of alcohol dehydrogenase, TM was also
increased in the case of other dehydrogenases for example in the case of wild-
type
glucose dehydrogenase when the enzyme was contacted with NAD or carbaNAD.
Table 8 shows the data obtained by DSC analysis for the various dehydrogenases
where in each case experimental conditions were selected which resulted in a
single
CA 02770249 2012-02-06
- 34 -
peak in the DSC spectrum. The effect of binding NAD or carbaNAD to the
dehydrogenase was compared in each case with scans in which no coenzyme
(ligand) was present. In each case 0.1 M Tris buffer, pH 8.5 was used as the
measurement buffer if not stated otherwise.
Table 8
dehydrogenase ligand Meal (kcal/mol) TM ( C)
--- 260 55.5
alcohol NAD 300 55.5
dehydrogenase* carbaNAD 310 55.4
glucose --- 64 52.8
dehydrogenase (wild- NAD 110 63.5
type) carbaNAD 84 58.5
D-lactate --- 18 58.4
dehydrogenase NAD 19 60.4
carbaNAD 19 59.1
L-lactate --- 80 59.8
dehydrogenase NAD 85 61.8
(porcine) carbaNAD 82 61.5
L lactate --- 64 58.2
dehydrogenase (from NAD 72 60.1
rabbit) carbaNAD 66 60.2
malate --- 310 42.4
dehydrogenase $ NAD 380 45.1
carbaNAD 340 43.2
* 0.75 M glycine sodium pyrophosphate, pH 9.0
0.1 M Tris buffer, pH 7.5
$ 0.5 M carbonate buffer, pH 10.0
